Skip to content
Open access

Sex-dependent dopaminergic vulnerability may contribute to sex differences in Parkinson’s disease risk

Aug 2026 · Brain Communications · Vol 8 · 0 citations · 32 references
Medicine

TL;DR

By distinguishing baseline variation from age-related changes in a selectively vulnerable dopaminergic system, this study provides population-scale evidence relevant to understanding sex differences in vulnerability to Parkinson’s disease.

Abstract

Abstract Men are more likely than women to develop Parkinson’s disease, yet the biological basis of this sex difference in Parkinson’s disease risk remains unresolved. The nigrosome-1 (NG-1), a dopaminergic subregion of the substantia nigra, is selectively vulnerable to degeneration and iron accumulation in Parkinson’s disease, therefore representing a plausible locus for sex-linked vulnerability. Using iron-sensitive magnetic resonance imaging from the UK Biobank, we examined sex differences in NG-1 magnetic susceptibility across adulthood. We analysed cross-sectional data from 53 792 individuals aged 45–85 years and longitudinal follow-up in 4068 participants. Across mid-to-late adulthood, men consistently exhibited higher NG-1 magnetic susceptibility than women, suggestive of greater iron-related signal burden. In contrast, age-related trajectories and rates of within-person change were similar between sexes, with no evidence for accelerated nigrostriatal ageing in men. Sensitivity analyses showed that these sex differences were not substantially modified by genetic risk for Parkinson’s disease, cardiometabolic disease or major lifestyle factors. Together, these findings suggest that sex differences in NG-1 susceptibility are expressed primarily as a stable baseline offset rather than divergent ageing dynamics. By distinguishing baseline variation from age-related changes in a selectively vulnerable dopaminergic system, this study provides population-scale evidence relevant to understanding sex differences in vulnerability to Parkinson’s disease.

Read PDF

Similar papers

Open access Oct 2026

Sex differences in genetic liability to modifiable Alzheimer's disease risk factors

NTRODUCTION: Alzheimer's disease (AD) shows sex differences in risk, clinical progression, and biomarker profiles, but whether inherited genetic liability to modifiable risk factors contributes differently to AD susceptibility in females and males remains unclear. We evaluated whether genetic relationships between seve...

R. Sharma, P. Tolosa-Tort, M. Okorie et al. · 0 citations
Open access Sep 2026

Spatially convergent functional MRI signatures of diabetes and male sex identify genetic vulnerabilities to accelerated brain ageing

Abstract Age-related cognitive decline results from complex interactions between neuroendocrine and neurometabolic processes that undergo lifelong degradation, yet the mechanisms underlying these interactions remain poorly understood. This study examined the effects of diabetes and sex on functional brain networks acro...

Anthony G. Chesebro, Luna R. Rohm, Botond B. Antal et al. · 0 citations
Review Open access Sep 2026

Sex differences in dementia with Lewy bodies: a systematic review

Compared to males, female patients with DLB were less likely to present with Rapid Eye Movement (REM) Sleep Behaviour Disorder, CSF biomarkers showed more Alzheimer’s Disease (AD) co-pathology, potentially contributing to misdiagnosis of DLB.

Heidi Isaksen, K. F. Bru, A. Shadrin et al. · 0 citations
Open access Sep 2026

Dopamine-Deficiency-Related Reorganization of the Somatomotor Network in Prodromal and Early Parkinson's Disease.

Dopaminergic depletion is associated with a targeted SMN reorganization, potentially maintaining network information flow despite progressive hub loss, and whether this reorganization represents compensation or a consequence of progressive pathology requires further longitudinal assessment.

Adrian L. Asendorf, Verena Dzialas, T. van Eimeren et al. · 0 citations
Open access Sep 2026

Selective nigrosome vulnerability in Parkinson’s disease revealed by histology-anchored ultra-high-field quantitative MRI

Selective vulnerability is a hallmark of Parkinson’s disease (PD): post-mortem, dopamine-containing cell loss in the substantia nigra first and most severely affects calbindin-poor compartments termed nigrosomes. Testing this in vivo has been limited by circularity, as MRI studies have delineated nigrosomes from the sa...

Rui-Yi Li, E. Kirilina, PL Bazin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.